Pune: Someone must take two covaxin doses even after recovering from Covid-19 because they are considered a fully vaccinated individual, the UNI Health Ministry official said on Saturday.
A recent study of the Indian Medical Research Council (ICMR) stated that one kovagin dose may be enough to protect infected by Covid-19 before taking a shot.
But the official clarified that at this time, there was no change in vaccination dose and no communication was released for it.
“According to the specified format, two doses must be taken for post-covid vaccination infections ICMR officials also stated that both vaccine doses would be ideal even for individuals who were previously infected for full vaccination.
The ICMR senior epidemiologist Dr.
Samiran Panda said, “full vaccination requires two doses, and this must be followed.” “Antibody response to the BBV152 vaccine in individuals previously infected with SARS-COV-2: pilot study” ICMR was carried out in 114 professional health care and frontline workers who used Covaxin shots from February to 2021.
found that those infected with Covid-19 and Taking a dose of Covaxin showed a similar immune response as a naive participant in Covid-19 infection that received a vaccine dose.
Studies published in Indian Medical Research Journal stated that initial data showed that a single dose of humoral immunity induced BBV152 in the previously infected individual equivalent to two vaccine doses in individual infection-naive.
It shows that “participants with the previous SARS-COV-2 infection, after a dose of one vaccine (BBV152) which gave rise to the levels of IgG (N) and IGG antibodies, along with the level of response inhibition of nab binder, which is similar to the infection-vaccinated naive has taken two doses of vaccines “.
According to ICMR, the findings of this study offer evidence to support vaccine strategies that are oriented to the health of the public and immunologically which can include recommend a one-dose regimen for those infected by Covid-19.
This finding needs to be confirmed with a large-size cohort study.
Dr.
Panda said further studies will be carried out.